American Vanguard vs Bioceres Crop Solutions
American Vanguard is the larger business, with $515m of revenue in fiscal 2025 against $238m for Bioceres Crop Solutions (2.2 times as much). American Vanguard grew faster (-5.9% against -17.7%). American Vanguard kept more of each dollar of sales as profit: a net margin of -9.7% against -110.8%. American Vanguard carries less debt relative to equity (90.4% against 1358.6%).
| Latest fiscal year | American VanguardAVD, 2025 | Bioceres Crop SolutionsBIOX, 2026 |
|---|---|---|
| Revenue | $515m | $238m |
| Revenue growth | -5.9% | -17.7% |
| Net income | −$49.9m | −$264m |
| Operating margin | -5.5% | -9.8% |
| Net margin | -9.7% | -110.8% |
| Return on equity | -23.4% | -191.2% |
| Free cash flow | −$25.1m | $65.0m |
| Cash | — | $11.2m |
| Total debt | $174m | $146m |
| Debt to equity | 90.4% | 1358.6% |
| Dividend per share | — | — |
| Dividend yield | 0.0% | 0.5% |
| Share buybacks | $0 | — |
| Employees | 739 | — |
| Market value | $30.8m | $14.3m |
| Price vs our value range | — | — |
| Moat score | 34 (Weak) | — |
| Insider trades, 12 months | 5 buys, 1 sales | 0 buys, 0 sales |